Delhi has 620 cases of ‘black fungus’, facing shortage of drugs, says Kejriwal

Black fungus has emerged as a potentially life-threatening Covid-19 complication that prompted the Centre last week to ask states to declare the disease notifiable under the Epidemic Diseases Act

Chief minister Arvind Kejriwal on Wednesday said there is a severe shortage of the medicine needed to treat at least 620 people undergoing treatment for mucormycosis, or black fungus, in Delhi’s hospitals.

A doctor examines a Covid-19 patient for black fungus infection. (PTI)

He added Delhi is receiving about 400 vials of anti-fungal amphotericin B needed to treat the fungal infection from the central quota even as it needs nearly 4,000 vials daily. “This is delaying the treatment in patients,” he said.

Black fungus has emerged as a potentially life-threatening Covid-19 complication that prompted the Centre last week to ask states to declare the disease notifiable under the Epidemic Diseases Act. A rare disease, experts and doctors say thousands have now contracted it because of an overuse of steroids or due to suppression of their immune system, which is often a fallout of attempts to stop the life-threatening immune overreaction due to Covid-19.

Black fungus cases went up 2.5 times last year between September and December across 16 centres in the country, according to Dr Arunaloke Chakrabarti, head of the department of microbiology at Post Graduate Institute of Medical Education & Research, Chandigarh. He is part of the Fungal Infection Study Forum and is one of the members, who drafted the government advisory on mucormycosis.